BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18523281)

  • 1. Molecular basis of the dual functions of 2B4 (CD244).
    Chlewicki LK; Velikovsky CA; Balakrishnan V; Mariuzza RA; Kumar V
    J Immunol; 2008 Jun; 180(12):8159-67. PubMed ID: 18523281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on "Molecular basis of the dual functions of 2B4 (CD244)".
    Yuan D
    J Immunol; 2008 Oct; 181(8):5181; author reply 5181. PubMed ID: 18832667
    [No Abstract]   [Full Text] [Related]  

  • 3. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2B4 inhibits NK-cell fratricide.
    Taniguchi RT; Guzior D; Kumar V
    Blood; 2007 Sep; 110(6):2020-3. PubMed ID: 17537992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2B4/CD48-mediated regulation of lymphocyte activation and function.
    Assarsson E; Kambayashi T; Persson CM; Chambers BJ; Ljunggren HG
    J Immunol; 2005 Aug; 175(4):2045-9. PubMed ID: 16081768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.
    Vaidya SV; Stepp SE; McNerney ME; Lee JK; Bennett M; Lee KM; Stewart CL; Kumar V; Mathew PA
    J Immunol; 2005 Jan; 174(2):800-7. PubMed ID: 15634901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
    Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
    J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
    Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
    J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
    Sandusky MM; Messmer B; Watzl C
    Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
    Margraf-Schönfeld S; Böhm C; Watzl C
    J Biol Chem; 2011 Jul; 286(27):24142-9. PubMed ID: 21606496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
    Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
    Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.
    Sinha SK; Gao N; Guo Y; Yuan D
    J Immunol; 2010 Nov; 185(9):5205-10. PubMed ID: 20881194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.
    Velikovsky CA; Deng L; Chlewicki LK; Fernández MM; Kumar V; Mariuzza RA
    Immunity; 2007 Oct; 27(4):572-84. PubMed ID: 17950006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells.
    Schlaphoff V; Lunemann S; Suneetha PV; Jaroszewicz J; Grabowski J; Dietz J; Helfritz F; Bektas H; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
    PLoS Pathog; 2011 May; 7(5):e1002045. PubMed ID: 21625589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.
    McNerney ME; Lee KM; Kumar V
    Mol Immunol; 2005 Feb; 42(4):489-94. PubMed ID: 15607804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.